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Of the vast number of new chemical entities
produced each year, only a handful ever
undergo assessment for developmental neuro-
toxicity, despite the fact that it is well recog-
nized that the immature brain is especially
vulnerable to toxicants (Barone et al. 2000;
Claudio et al. 2000). Accordingly, there is a
need for high-throughput screens that might
help focus and limit testing in mammalian
models to those compounds most likely to
elicit adverse effects. In this regard, the embryos
and larvae of lower organisms, notably the sea
urchin, appear to be promising candidates
(Buznikov 1983; Buznikov et al. 1997, 2001b,
2003; Hagstrom and Lonning 1973; Pesando
et al. 2003). In these species, just as in the
developing mammalian brain, neurotransmit-
ters such as acetylcholine (ACh), serotonin,
norepinephrine, and dopamine serve as devel-
opmental (trophic) signals controlling the tim-
ing of cell replication and differentiation, cell
death, and architectural organization (Buznikov
et al. 1964, 2001a; Buznikov and Podmarev
1990; Gustafson and Toneby 1970; Hohmann
and Berger-Sweeney 1998; Lauder 1985;
Lauder and Schambra 1999; Weiss et al. 1998).
Accordingly, substances that alter mammalian
brain development, through their promotion or
antagonism of neurotransmitter actions, elicit
gross dysmorphology in sea urchin embryos,
with critical periods corresponding to develop-
mental surges in transmitter levels and the
appearance of the appropriate receptors for the
transmitters.
A number of articles have detailed the spe-
cific role played by ACh (for review, see
Hohmann and Berger-Sweeney 1998; Lauder
and Schambra 1999). In the case of mam-
malian brain development, this transmitter
provides a focus for understanding the adverse
effects of two major classes of insecticides, the
organophosphates and the carbamates, which
operate through inhibition of cholinesterase,
as well as the effects of nicotine, the major
developmental neurotoxicant in tobacco
smoke (Barone et al. 2000; Pope 1999; Rice
and Barone 2000; Slotkin 1998, 1999). In
addition, a wide variety of neurotoxicants
appear to converge secondarily on cholinergic
function as a contributory end point to their
actions on brain development (Yanai et al.
2002). As reviewed a number of years ago
(Buznikov 1990), ACh, along with its relevant
biosynthetic/biodegradative enzymes and
receptors, is present even in unfertilized sea
urchin eggs, as well as in zygotes and other
“pre-nervous” developmental stages. The con-
centration of ACh exhibits distinct peaks dur-
ing early cleavage divisions, but the major,
sustained increases occur after the beginning
of gastrulation, in tandem with transcription
of zygotic genes and attendant rises in choline
acetyltransferase, the enzyme that synthesizes
ACh (Buznikov et al. 1968; Buznikov and
Podmarev 1990; Falugi et al. 2002). In accord
with the trophic role of ACh, both ACh
antagonists and agonists that are known to
exert developmental neurotoxicant actions in
mammals perturb sea urchin development,
with periods of sensitivity corresponding to
the surges in ACh levels (Buznikov 1990;
Buznikov et al. 1968, 1996, 1997, 2001a,
2001b; Buznikov and Podmarev 1990;
Buznikov and Rakic 2000; Gustafson and
Toneby 1970; Pesando et al. 2003).
To our knowledge, no studies have
appeared on the ontogeny and trophic role of
the high-afﬁnity choline transporter in the sea
urchin. In the mammalian brain, choline trans-
port, and not the activity of choline acetyltrans-
ferase, is the rate-limiting step in ACh
biosynthesis and the locus of regulation of ACh
levels (Klemm and Kuhar 1979; Simon et al.
1976). Inhibition of choline transport by hemi-
cholinium-3 (HC-3) or its analogs, such as
dimethylaminoethanol (DMAE), elicits neural
tube defects in mammalian embryos (Fisher
et al. 2002); later in development, toxicant
effects on choline transport make major contri-
butions to neurobehavioral perturbations (Dam
et al. 1999; Happe and Murrin 1992; Sawin et
al. 1998; Slotkin et al. 2001; Steingart et al.
1998, 2000; Zahalka et al. 1992, 1993; Zhu et
al. 2000). In the present study, we demon-
strate the presence of the high-afﬁnity choline
transporter in sea urchin embryos and larvae,
the development of the transporter over the
period in which this organism uses ACh as a
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Embryonic development in the sea urchin requires trophic actions of the same neurotransmitters
that participate in mammalian brain assembly. We evaluated the development of the high-afﬁnity
choline transporter, which controls acetylcholine synthesis. A variety of developmental neurotoxi-
cants affect this transporter in mammalian brain. [3H]Hemicholinium-3 binding to the transporter
was found in the cell membrane fraction at stages from the unfertilized egg to pluteus, with a bind-
ing afﬁnity comparable with that seen in mammalian brain. Over the course of development, the
concentration of transporter sites rose more than 3-fold, achieving concentrations comparable with
those of cholinergically enriched mammalian brain regions. Dimethylaminoethanol (DMAE), a
competitive inhibitor of choline transport, elicited dysmorphology beginning at the mid-blastula
stage, with anomalies beginning progressively later as the concentration of DMAE was lowered.
Pretreatment, cotreatment, or delayed treatment with acetylcholine or choline prevented the
adverse effects of DMAE. Because acetylcholine was protective at a lower threshold, the DMAE-
induced defects were most likely mediated by its effects on acetylcholine synthesis. Transient
removal of the hyaline layer enabled a charged transport inhibitor, hemicholinium-3, to penetrate
sufficiently to elicit similar anomalies, which were again prevented by acetylcholine or choline.
These results indicate that the developing sea urchin possesses a high-afﬁnity choline transporter
analogous to that found in the mammalian brain, and, as in mammals, the functioning of this
transporter plays a key role in the developmental, trophic activity of acetylcholine. The sea urchin
model may thus be useful in high-throughput screening of suspected developmental neurotoxicants.
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able via http://dx.doi.org/ [Online 30 July 2003]trophic signal, anomalies associated with inhi-
bition of choline transport, and proof that
these adverse effects are related to inhibition
of ACh synthesis, rather than other aspects of
choline availability.
Materials and Methods
Adult specimens of Lytechinus variegatus were
maintained in tanks with continuously fil-
tered, circulating artificial seawater (ASW).
Gametes were harvested and the eggs were fer-
tilized and incubated as described previously
(Buznikov et al. 2001b, 2003; Buznikov and
Podmarev 1990). Embryos and larvae were
cultured, and all experiments conducted, at
approximately 22°C.
Development of the high-affinity choline
transporter. For biochemical analyses, we used
the material from 22 ripe females at the fol-
lowing stages: unfertilized eggs; embryos at
2–4 blastomeres (2 hr postfertilization), 16
blastomeres (3 hr), early blastula 1 (4.5 hr),
and mid-blastula 2 (9.5 hr); and larvae at late
blastula 1 (12 hr), prism 2 (25.7 hr), early plu-
teus 2 (34.3 hr), and mid-pluteus 1 (47.5 hr).
The suspensions of eggs, embryos, or larvae
were washed with 0.55 M KCl and sedi-
mented, whereupon the precipitates were
frozen and kept at –80°C. All embryonic
stages and the ﬁrst larval stage are pre-nervous,
with the first neurons arising at the prism 2
stage and the plutei possessing the larval ner-
vous system. The normal developmental stages
of sea urchins, including L. variegatus embryos
and larvae, have been published previously
(Buznikov 1990; Buznikov and Podmarev
1990; Buznikov et al. 2003) and also are avail-
able on the Internet (Leland Stanford Junior
University 2003).
Samples were thawed and homogenized
(Polytron, Brinkmann Instruments, Westbury,
NY, USA) in ice-cold 10 mM sodium–potas-
sium phosphate buffer (pH 7.4) and sedi-
mented at 40,000 × g for 15 min. The
supernatant solution was discarded, and the
membrane pellet was resuspended (Polytron)
and resedimented in the same buffer, after
which the resultant pellet was resuspended
using a glass homogenizer ﬁtted with a Teﬂon
pestle, in 10 mM sodium–potassium phosphate
and 150 mM NaCl (pH 7.4). Radioligand
binding to the transporter was evaluated using
2 nM [3H]HC-3 (Vickroy et al. 1984; Zahalka
et al. 1992), with incubation for 20 min at
room temperature, followed by rapid vacuum
ﬁltration onto glass ﬁber ﬁlters that were pre-
soaked for 30 min in 0.1% polyethyleneimine.
The nonspecific component was defined as
radioligand binding in the presence of an excess
concentration (10 µM) of unlabeled HC-3.
Binding values were expressed relative to mem-
brane protein (Smith et al. 1985). A standard
preparation of adult rat midbrain was used as a
control to enable standardization across batches
of assays required to assess different develop-
mental stages.
To verify that HC-3 binding involved the
high-affinity transporter, we performed
Scatchard analysis at two developmental stages
corresponding to low and high levels of bind-
ing: mid-blastula 2 and mid-pluteus 1.
Radioligand binding was evaluated over a range
of [3H]HC-3 concentrations (0.1–3.2 nM)
chosen so as to bracket the Kd value found for
the transporter in the mammalian brain
(Vickroy et al. 1984; Zahalka et al. 1992).
Effects of transport inhibitors on develop-
ment. Embryos and larvae were obtained from
12 females, one for each series of experiments.
Fertilized eggs, suspended in ASW, were
placed in multiwell cell culture clusters, at
approximately 150 eggs per well in a volume
of 2 mL, and were incubated at approximately
22°C throughout the experiment up to the
final, digitally captured images. Test sub-
stances (HC-3, DMAE, ACh, choline) were
introduced at the one-cell stage (0.5–0.75 hr
after fertilization), two-to-four–cell stage
(1.3–2 hr), or mid-blastula 1 stage (7–8 hr).
Embryos and larvae in control wells were
incubated in pure ASW or in ASW with cor-
responding volumes of vehicles used for disso-
lution of the test chemicals (DMSO for
HC-3, distilled water for other stock solu-
tions). The addition of vehicle alone had no
impact on embryonic or larval development.
In some experiments, the eggs were preincu-
bated brieﬂy (5–10 min immediately after fer-
tilization) with 1 M glycine to remove the
hyaline layer so as to permit permeation of
highly charged quaternary ammonium com-
pounds such as HC-3 (Kane 1973). Freshly
formed interblastomere contacts are tran-
siently permeable to hydrophilic substances
during the ﬁrst third of the ensuing cell cycle
(Dale et al. 1982; Korobtzov and Sorokin
1974; Sanger et al. 1985), so we anticipated
that we could achieve entry of highly charged
molecules into the embryo during the first
few cell cycles after temporary dehyalination.
Embryonic and larval development were
viewed continuously in the live organisms
without any fixation, using a Leitz Wetzlar
microscope in brightﬁeld transmission mode,
with a color digital video camera (Spot;
Diagnostic Instruments, Sterling Heights, MI,
USA) connected to a computer to capture the
images. As described previously (Buznikov
et al. 2001b), all embryos or larvae in a given
well were digitized at low magniﬁcation (40×).
As a rule, all (100%) organisms receiving a spe-
ciﬁc treatment showed the same phenotype, so
representative specimens were then digitized at
higher magniﬁcations. We recorded the ages of
embryos and larvae (time after fertilization)
during digitization of results.
Data analysis. Data for HC-3 binding are
presented as means and standard errors, with
comparisons across developmental stages car-
ried out by analysis of variance (ANOVA), fol-
lowed by intergroup comparisons using
Fisher’s protected least signiﬁcant difference.
Scatchard plots were ﬁtted by linear regression
analysis and compared using analysis of covari-
ance (ANCOVA). Significance was assumed
at p < 0.05. Malformations caused by trans-
porter inhibition are shown qualitatively; how-
ever, as described previously (Buznikov et al.
2001b), these effects are uniform over the
entire population and represent observations
made in > 3,000 embryos under each condi-
tion. In no case did control embryos or larvae
show any malformations.
Materials. Sea urchins were obtained from
Jennifer Keller (Duke University Marine Lab,
Beaufort, NC, USA) and Susan Decker
(Miami, FL, USA). [3H]HC-3 (speciﬁc activ-
ity, 161 Ci/mmol) was purchased from
PerkinElmer Life Sciences (Boston, MA, USA).
All other compounds were obtained from
Sigma-Aldrich Corp. (St. Louis, MO, USA).
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Figure 1. (A) Development of [3H]HC-3 binding sites
(mean ± SE) in the sea urchin embryo at a single,
subsaturating ligand concentration (2 nM); these
values allow for detection of effects on either the
concentration of binding sites or the afﬁnity of the
site for the ligand. ANOVA: p < 0.0006 (n = 3–5 per
stage). (B) Scatchard determinations of binding
affinity and the concentration of transporter sites
at two stages; results indicate a significant
increase in the total concentration of sites (Bmax)
but not in the dissociation constant for binding of
the ligand to the site (Kd). Abbreviations: B, bound
ligand; F, free ligand. The Kd (nM) and Bmax
(fmol/mg/mg protein) are, respectively, 1.4 ± 0.6
and 126 ± 24 for mid-blastula 2 and 1.1 ± 0.2 and 212
± 22 for mid-pluteus 1; ANCOVA: p <0 .005.
*Significant compared to unfertilized egg. †Significant
compared to mid-pluteus 1.
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Comparisons of [3H]HC-3 binding across all
developmental stages were ﬁrst conducted at a
single, subsaturating ligand concentration
(2 nM), which allows differences to be
detected regardless of whether there are shifts
in the concentration of transporter sites or in
their afﬁnity for the ligand. Even in the unfer-
tilized egg, there was significant [3H]HC-3
binding associated with the cell membrane
fraction (Figure 1A). The amount of binding
doubled by the stage and then rose more sub-
stantially at late blastula 2 stage and beyond.
To verify that the HC-3 binding represented
its association with the high-affinity choline
transporter, and to determine whether the dif-
ferences reﬂected alterations in the concentra-
tion of sites, we performed Scatchard analysis
at mid-blastula 2 and mid-pluteus 1 stages
(Figure 1B). At both stages, the Kd was in the
low nanomolar range, comparing favorably
with the afﬁnity of HC-3 for the high-afﬁnity
transporter in mammalian brain (Vickroy et al.
1984; Zahalka et al. 1992). The developmental
increase between these two stages represented
primarily an increase in the concentration of
transporter sites, as evidenced by a signiﬁcant
main effect of age (ANCOVA), reﬂecting an
increase in the Bmax of binding, without sig-
niﬁcant changes in slope that would indicate
a shift in Kd.
We next evaluated whether the function-
ing of the putative choline transporter played
a role in trophic control of embryonic devel-
opment. Because of limitations of permeabil-
ity, we initially studied DMAE, a membrane-
permeable analog of HC-3 (Alkadhi 1986;
Fisher et al. 2002). DMAE added to the
embryos at the two-cell stage in concentra-
tions of 100–400 µM did not alter cleavage
divisions or blastulation, but at very high con-
centrations (600–800 µM), cleavages were
inhibited (Figures 2 and 3). If the latter effect
represents interference with high-affinity
choline transport and the resultant deﬁciency
in ACh, then the introduction of ACh or
choline should prevent the inhibition.
However, this was not the case: concentra-
tions of either agent up to 800 µM failed to
restore the ability to divide (Figure 2).
Although cleavage divisions were affected
only at very high DMAE concentrations,
embryos treated with lower concentrations at
the two-cell stage subsequently developed mal-
formations (Figure 3): overabundance of mes-
enchyme-like cells that accumulated ﬁrst in the
vegetal half of the blastocoel, and later occu-
pied all of the blastocoel, blocking or inhibit-
ing gastrulation; absence of a second pair of
arms in mid-pluteus, or sometimes shortening
or absence of one arm of the first pair
(Figure 3H). At the highest concentrations
(300–400 µM), dysmorphology was evident at
the late blastula stage, whereas at 200–400 µM,
anomalies emerged at gastrulation, followed at
the lowest concentrations (100–200 µM) by
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Figure 2. Effects of DMAE, introduced at the two-cell stage, on early cleavage divisions. At concentrations up to 200 µM, there were no effects of DMAE: (A) control,
5 hr 18 min after fertilization, early blastula 2 stage; (B) 200 µM DMAE, showing normal embryonic development at this stage. At 600–800 µM, cleavage divisions are
inhibited: (C) control, 11 hr 20 min after fertilization, late blastula 2 stage; (D) 800 µM DMAE, showing abnormal (an) or dead (d) embryos, with development blocked at
the 4-, 8-, or 16-cell stage. Treatment with 800 µM DMAE and (E) 800 µM ACh or (F) choline fails to prevent the effects of DMAE (late blastula 2 stage). Bar = 50 µm.
AB CDEF
Figure 3. Malformations after introduction of DMAE at the two-cell stage. Abbreviations: Ar, primary gut or archenteron; Lw, larval wall. (A) Control, 4 hr after fer-
tilization, early blastula 1 stage. (B) 800 µM DMAE, showing abnormal embryos with developmental block at the four-to-eight–cell stage. (C) Control, 10 hr 20 min
after fertilization, late blastula 1 stage, showing a blastula cavity or blastocoel (Bn) with few mesenchyme cells. (D) 400 µM DMAE, showing hyperproduction of
mesenchyme-like pigmented cells (Ml) in the blastocoel, with these cells sometimes leaking (Lea) from the blastocoel. (E) Control, 23 hr 25 min after fertilization,
prism 1 stage. (F) 200 µM DMAE, showing underdevelopment or absence of archenterons, that is, inhibition of gastrulation. (G) Control, 49 hr after fertilization,
early pluteus 2 stage, showing ﬁrst (1st) and second (2nd) pairs of arms. (H) 100 µM DMAE, dwarf larvae, showing absence of a second pair of arms, shortening of
the ﬁrst pair, or absence of one of the arms of the ﬁrst pair (1 Arm). Bar = 50 µm for A–F; bar = 100 µm for G and H.
2nd
1st
1st
1 Arm
Ar Ar
MI
Lw
Lea
Lw
Bn B CD A
E F GHabnormalities at the pluteus stage. These mal-
formations were all elicited in a similar fashion,
regardless of whether DMAE was introduced
before cleavage divisions, during the ﬁrst few
divisions or as late as the mid-blastula stage.
In contrast to the lack of protection offered
by ACh or choline for the effects of DMAE on
cleavage divisions, we found that either agent,
introduced 10–15 min before, simultaneously
with, or 30–60 min after DMAE, provided
protection against the delayed-onset disruption
of the later developmental events (Figure 4).
For ACh, there was partial protection above a
threshold concentration of about 25 µM.
Choline was somewhat less effective, requiring
a higher threshold concentration for a protec-
tive effect: 50 µM choline did not prevent mal-
formations resulting from DMAE treatment
but 200 µM (equimolar to DMAE) achieved
complete protection.
Permeability factors may limit the protec-
tive effect of ACh or choline because both of
these contain quaternary ammonium groups,
just like HC-3. To characterize this problem,
we compared the effects of HC-3 with DMAE
in intact embryos and larvae (Figure 5).
Concentrations of HC-3 up to 80 µM failed to
have any discernible effect on development,
despite the fact that this concentration is more
than two orders of magnitude above the Kd
that we found for the binding of HC-3 to the
transporter. Accordingly, we next produced
transient elimination of the hyaline layer by a
brief incubation with 1 M glycine, a treatment
that does not disturb embryonic development
but that produces a short-duration permeation
to charged molecules. This procedure rendered
the embryos sensitive to HC-3 (Figure 6).
With the introduction of 20–80 µM HC-3,
embryos developed quite normally up to the
mid-blastula stage, at which time they mani-
fested the same archetypal developmental mal-
formations as seen with DMAE (compare
Figure 6A with Figure 4A). Similarly, intro-
ducing ACh or choline during the permeation
period then protected the developing organism
from HC-3. In this case, ACh was able to pro-
tect the embryo fully at concentrations of
25–800 µM; choline gave only partial protec-
tion at concentrations equimolar to HC-3,
whereas lower concentrations were less effective
or ineffective.
Discussion
Results obtained in the present study indicate
that the developing sea urchin embryo possesses
a high-afﬁnity choline transporter whose bio-
chemical and pharmacologic properties resem-
ble those found for the transporter present in
the mammalian brain, and that this transporter
plays a similar role in the trophic functions of
ACh. We used differential sedimentation to
isolate the cell membrane fraction and found
signiﬁcant, saturable [3H]-labeled HC-3 bind-
ing even in the unfertilized egg, with progres-
sive increases through development to the
pluteus stage. This site displayed the same char-
acteristic, high-afﬁnity binding (nanomolar Kd)
of HC-3 as in the mammalian brain, and by
mid-pluteus 1, the concentration of binding
sites relative to membrane protein was > 200
fmol/mg, comparable with mammalian brain
regions that are enriched in cholinergic nerve
terminals (Zahalka et al. 1992). Future studies
should be able to identify whether the protein
that mediates high-afﬁnity choline transport in
the sea urchin is indeed highly homologous to
the transporter in mammalian brain, or
whether the two proteins represent convergent
evolution. Regardless of the actual amino acid
sequences of the proteins, the main importance,
as studied here, lies in the fact that the trans-
porter plays a similar trophic role in sea urchin
development as in mammalian brain, and that
it responds to neurotoxicants in the same way.
In cholinergic neurons, high-affinity
choline transport provides the control point
for ACh synthesis (Klemm and Kuhar 1979;
Simon et al. 1976) and is a major site of alter-
ations induced by developmental neuro-
toxicants that affect cholinergic trophic or
synaptic function (Barone et al. 2000; Pope
1999; Rice and Barone 2000; Slotkin 1998,
1999; Yanai et al. 2002). If the transporter
plays a similar role in the morphologic assem-
bly of the sea urchin embryo, then pharmaco-
logic interference with the transporter should
evoke distinct malformations. We observed
such effects for DMAE, an analog of HC-3
that can readily penetrate the hyaline layer and
cell-surface membranes of the embryo, but
there were two distinct phases of effect. High
concentrations of DMAE interfered with early
cleavage divisions, an effect that was not
antagonized by coadministration of ACh or
choline. Accordingly, the actions of DMAE at
these stages may involve secondary actions
unrelated to inhibition of choline transport.
On the other hand, it is clear from previous
work that ACh does play a role in triggering
cleavage divisions in sea urchins (Buznikov et
al. 1970). It is therefore likely that activity of
the transporter is relatively unimportant at
that stage, perhaps because of high levels of
Article | Sea urchin embryo choline transporter
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Figure 4. Effects of DMAE (200 µM) on developing sea urchin embryos and the protective effects of ACh and choline. Test substances were added at the two-cell
stage (1 hr 25 min after fertilization), and larvae were examined 22 hr 50 min after fertilization (prism 1 stage in the controls). (A) DMAE alone; development is
blocked at the late blastula 2 to early gastrula 1 stages, with hyperproduction of mesenchyme-like cells near the primary mouth or blastopore (Bp). (B) DMAE plus
12.5 µM ACh produces nearly the same effect as with DMAE alone, but for 20–30% of the larvae, development is blocked later, at the early gastrula 2 to mid-
gastrula 1 stages, representing slight protection. (C) DMAE plus 25 µM ACh; development is blocked at the mid-gastrula 2 stage (moderate protection). (D) DMAE
plus 50 µM ACh; blockage is postponed to mid-gastrula 2 to late gastrula 1 stages (moderate protection). (E) DMAE plus 50 µM choline, showing no protection.
(F) DMAE plus 100 µM choline, showing slight protection (normal larvae, as in H). (G) DMAE plus 200 µM choline, showing full protection (normal larvae).
(H) Controls raised in ASW alone reach the prism 2 stage. Bar = 50 µm.
A B C D
E F G H
Bp
Bpendogenous choline stored in the yolk granules
before fertilization.
We obtained very different results for
effects of DMAE arising at the mid-blastula
stage and later. The mid-blastula represents a
point of rapid transcription of zygotic genes
(Buznikov 1983, 1990; Buznikov et al. 1996,
1997; Buznikov and Podmarev 1990);
accordingly, this is the stage at which effects
of environmental toxicants on the program-
ming of trophin/differentiation interactions,
and most especially those of cholinotoxicants,
are most likely to emerge (Buznikov 1990;
Buznikov et al. 1968, 1996, 1997, 2001a,
2001b, 2003; Buznikov and Podmarev 1990;
Buznikov and Rakic 2000; Gustafson and
Toneby 1970; Pesando et al. 2003). Here, we
found a dose-dependent effect of DMAE that
operated with a distinctly lower threshold
than for inhibition of cleavage divisions, with
the onset of anomalies shifting to later and
later stages as the dose was lowered. Equally
important, the embryos were protected from
the effects of DMAE by inclusion of either
ACh or choline, thus indicating a mechanistic
connection to the activity of the choline
transporter. That ﬁnding alone does not iden-
tify ACh as the important trophic factor
because deficiencies in choline could also
affect membrane integrity through interfer-
ence with phosphatidylcholine synthesis, a
mechanism proposed for DMAE’s ability to
produce neural tube defects in mammals
(Fisher et al. 2002). It is therefore critical that
we found a lower threshold for protection by
ACh compared with choline. Conceivably,
ACh could be broken down to choline by the
action of cholinesterase, but under no circum-
stance would ACh then be more effective
than equimolar concentrations of choline.
Accordingly, our results are consistent with a
fundamental role for the high-afﬁnity choline
transporter in the synthesis of ACh required
by the developing sea urchin for morphologic
assembly during and after the rise in zygotic
gene transcription at the mid-blastula stage.
One limitation of any proposed cell culture
system or invertebrate model for developmental
neurotoxicity is that the fetal mammalian brain
is typically protected by diffusion barriers: the
placenta (Sastry 1991) and, depending on the
stage of development, the blood–brain barrier
(Saunders and Møllgard 1984). Similarly, the
sea urchin embryo is protected by a hyaline
barrier that, like the placenta and blood–brain
barrier, tends to retard the penetration of
charged molecules. We were able to distinguish
between permeant and nonpermeant inhibitors
of the choline transporter by comparing effects
of DMAE with the quaternary ammonium–
containing analog HC-3. Without removal of
the hyaline barrier, HC-3 was totally ineffec-
tive in eliciting the delayed-onset defects asso-
ciated with inhibition of the choline
transporter. The hyaline layer speciﬁcally pro-
tects the highly permeable zones of the freshly
formed interblastomere contacts during the
first few cell divisions (Dale et al. 1982;
Korobtzov and Sorokin 1974; Sanger et al.
1985). Dehyalination opens these diffusion
barriers for a brief period during each cell cycle,
and even these few episodes of permeation
were sufﬁcient to allow HC-3 to penetrate and
produce the same anomalies as seen with
DMAE. Again, the specific role of ACh was
demonstrable in the protective effects of ACh
and choline. This means that the sea urchin
provides a way for testing different compounds
in the same chemical class for the role of per-
meation in their ability to elicit developmental
anomalies, namely, by comparing effects with
and without dehyalination. Accordingly, the
sea urchin may also afford an appropriate
model with which to predict the relative
importance of diffusion barriers that operate to
protect the fetal mammalian brain.
In conclusion, the developing sea urchin
embryo possesses a high-afﬁnity choline trans-
porter whose expression increases greatly over
the period in which the embryo uses ACh as a
trophic signal. Inhibitors of transport elicit a
Article | Qiao et al.
1734 VOLUME 111 | NUMBER 14 | November 2003 • Environmental Health Perspectives
Figure 5. Intact sea urchin larvae are insensitive to
70 µM HC-3. Test substances were added at the one-
cell stage, 40 min after fertilization, and larvae were
examined at 26–27 hr. (A) Controls (0.4% DMSO in
ASW) have reached the prism 2 to early pluteus 1
stages. (B) The HC-3–exposed group appears nor-
mal. Abbreviations: 1st, buds of the ﬁrst pair of arms;
Ar, upper end of archenterons and secondary mouth.
Bar = 50 µm.
A
B
1st
1st
1st
1st
Ar
Ar
Figure 6. Dehyalination with glycine (see “Materials and Methods” for details) allows HC-3 to penetrate the embryo and elicit malformations. Test substances
were added at the one-cell stage (40 min after fertilization); larvae are shown 25 hr after fertilization. (A) Effects of 40 µM HC-3; development is blocked at the late
blastula 2 to early gastrula 1 stages, again with hyperproduction of mesenchyme-like cells (Ml) near the blastopore (Bp) (see Figure 4A). (B) HC-3 plus 200 µM
ACh; most larvae are normal (full protection). (C) HC-3 plus 200 µM choline, showing clear but incomplete protection. (D) Control (0.4% DMSO in ASW) at the
prism 1 stage. Bar = 100 µm.
A B
MI
Bp
C Dcharacteristic pattern of delayed-onset malfor-
mations that do not arise until the mid-blastula
stage, the same period when cholinotoxicants
disrupt morphologic development. Adverse
effects of DMAE and HC-3 were offset by
either ACh or choline, indicating that the
transporter plays the same critical role in the
control of ACh levels as it does in the mam-
malian brain. Furthermore, the hyaline barrier
provides protection of the embryo from
charged molecules, just as the placenta and
blood–brain barrier do for the fetal mam-
malian brain, and the technique of transient
dehyalination can therefore be used to model
the protective effect of these diffusion barriers
against potential toxicants. Each female sea
urchin provides many thousands of eggs. After
fertilization, these large numbers of embryos
can be evaluated quickly with simple light
microscopy and video capture, yielding robust,
obvious, and uniform dysmorphologies as a
result of exposure to compounds that are likely
to produce far more subtle neurochemical and
behavioral alterations in the developing mam-
malian brain. The sea urchin embryo may
therefore provide a high-throughout screen for
developmental neurotoxicants.
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